ArticleFrontiers in cardiovascular medicine2026
Single-catheter radiofrequency pulmonary vein isolation for atrial fibrillation: a comparative evaluation.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Circular mapping catheters (CMC) are used to confirm pulmonary vein isolation (PVI) in radiofrequency (RF) ablation for atrial fibrillation (AF), but may be unnecessary in CLOSE-style point-by-point workflows. We evaluated whether omitting the CMC preserves efficacy and improves efficiency in first-time PVI. Methods: We conducted a single-center, hybrid prospective-retrospective comparison of consecutive first-time PVI cases. A CMC-guided cohort ( Results: CMC-free cases had shorter procedures [105 (90, 120) vs. 120 (110, 135) min, Conclusion: In CLOSE-style first-time RF PVI, a CMC-free, single-catheter workflow was associated with improved procedural efficiency and no significant difference in observed 12-month arrhythmia outcomes. These findings are hypothesis-generating. Prospective randomized studies are needed to confirm the safety and efficacy of this approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.